Jafron Biomedical Co.,Ltd. (SHE: 300529)
China
· Delayed Price · Currency is CNY
32.64
-0.95 (-2.83%)
Oct 11, 2024, 9:44 AM CST
Jafron Biomedical Co.,Ltd. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 1,749 | 2,810 | 2,559 | 2,319 | 1,575 | 1,272 | Upgrade
|
Trading Asset Securities | 1,006 | - | - | 150.01 | - | - | Upgrade
|
Cash & Short-Term Investments | 2,755 | 2,810 | 2,559 | 2,469 | 1,575 | 1,272 | Upgrade
|
Cash Growth | -3.23% | 9.83% | 3.62% | 56.79% | 23.85% | 17.67% | Upgrade
|
Accounts Receivable | 82.22 | 81.21 | 239.64 | 308.06 | 215.8 | 160.66 | Upgrade
|
Other Receivables | 19.33 | 6.51 | 6.85 | 6.32 | 9.78 | 9.16 | Upgrade
|
Receivables | 101.55 | 87.72 | 246.49 | 314.37 | 225.58 | 169.82 | Upgrade
|
Inventory | 320.08 | 385 | 349.13 | 196.55 | 120.67 | 92.31 | Upgrade
|
Prepaid Expenses | - | 0.32 | 14.55 | - | - | - | Upgrade
|
Other Current Assets | 32.87 | 28.5 | 124.32 | 75.27 | 65.31 | 25.88 | Upgrade
|
Total Current Assets | 3,210 | 3,312 | 3,293 | 3,056 | 1,987 | 1,560 | Upgrade
|
Property, Plant & Equipment | 1,786 | 1,771 | 1,672 | 1,272 | 905.51 | 639.63 | Upgrade
|
Long-Term Investments | 116.13 | 116.13 | 69.45 | 111.2 | 98.99 | 100.79 | Upgrade
|
Goodwill | 12.21 | 12.21 | 37.81 | 44.07 | 44.07 | 44.07 | Upgrade
|
Other Intangible Assets | 98.62 | 100.37 | 100.43 | 101.31 | 89.89 | 48.05 | Upgrade
|
Long-Term Deferred Tax Assets | 31.24 | 30.35 | 36.49 | 26.54 | 12.97 | 10.07 | Upgrade
|
Long-Term Deferred Charges | 90.36 | 94.87 | 59 | 35.95 | 20.42 | 14.82 | Upgrade
|
Other Long-Term Assets | 113.81 | 107.03 | 148.22 | 162.91 | 58.22 | 77.49 | Upgrade
|
Total Assets | 5,458 | 5,543 | 5,417 | 4,810 | 3,217 | 2,495 | Upgrade
|
Accounts Payable | 155.12 | 135.62 | 128.52 | 60.76 | 50.22 | 32.83 | Upgrade
|
Accrued Expenses | 165.12 | 158.21 | 157.48 | 192.98 | 139.79 | 98 | Upgrade
|
Short-Term Debt | 316.93 | 261.83 | 317.09 | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | 100.59 | 16.79 | - | - | - | - | Upgrade
|
Current Portion of Leases | 1.9 | 3.83 | 4.73 | 3.17 | - | - | Upgrade
|
Current Income Taxes Payable | 60.54 | 30.52 | 2.55 | 23.19 | 52.14 | 23.63 | Upgrade
|
Current Unearned Revenue | 23.56 | 37.57 | 42.3 | 20.65 | 26.95 | 7.97 | Upgrade
|
Other Current Liabilities | 185.14 | 185.03 | 64.52 | 85.51 | 61.73 | 100.2 | Upgrade
|
Total Current Liabilities | 1,009 | 829.42 | 717.18 | 386.26 | 330.82 | 262.63 | Upgrade
|
Long-Term Debt | 1,249 | 1,381 | 936.78 | 897.37 | - | - | Upgrade
|
Long-Term Leases | 0.6 | 11.35 | 17.34 | 17.01 | - | - | Upgrade
|
Long-Term Unearned Revenue | 140.53 | 151.78 | 151.66 | 125.08 | 51.7 | 60.68 | Upgrade
|
Long-Term Deferred Tax Liabilities | 14.09 | 16.78 | 3.12 | 0.73 | 0.54 | 0.81 | Upgrade
|
Total Liabilities | 2,413 | 2,390 | 1,826 | 1,426 | 383.06 | 324.13 | Upgrade
|
Common Stock | 807.56 | 807.56 | 807.71 | 805.5 | 799.11 | 418.66 | Upgrade
|
Additional Paid-In Capital | 711.78 | 694.14 | 678.04 | 618 | 347.9 | 606.05 | Upgrade
|
Retained Earnings | 2,650 | 2,408 | 2,507 | 2,336 | 1,670 | 1,173 | Upgrade
|
Treasury Stock | -1,248 | -880.63 | -509.69 | -523.8 | -13.52 | -59.65 | Upgrade
|
Comprensive Income & Other | 118.63 | 118.63 | 91.7 | 123.14 | 3.08 | 4.62 | Upgrade
|
Total Common Equity | 3,040 | 3,147 | 3,574 | 3,359 | 2,807 | 2,142 | Upgrade
|
Minority Interest | 5.02 | 5.4 | 16.17 | 24.79 | 26.82 | 28.06 | Upgrade
|
Shareholders' Equity | 3,045 | 3,153 | 3,590 | 3,384 | 2,834 | 2,171 | Upgrade
|
Total Liabilities & Equity | 5,458 | 5,543 | 5,417 | 4,810 | 3,217 | 2,495 | Upgrade
|
Total Debt | 1,669 | 1,675 | 1,276 | 917.55 | - | - | Upgrade
|
Net Cash (Debt) | 1,086 | 1,135 | 1,283 | 1,552 | 1,575 | 1,272 | Upgrade
|
Net Cash Growth | -1.22% | -11.49% | -17.34% | -1.47% | 23.85% | 17.67% | Upgrade
|
Net Cash Per Share | 1.36 | 1.43 | 1.62 | 1.93 | 1.94 | 1.60 | Upgrade
|
Filing Date Shares Outstanding | 774.47 | 774.47 | 798.87 | 815.46 | 798.53 | 795.46 | Upgrade
|
Total Common Shares Outstanding | 774.47 | 774.47 | 798.86 | 815.46 | 799.11 | 795.46 | Upgrade
|
Working Capital | 2,201 | 2,482 | 2,576 | 2,669 | 1,656 | 1,297 | Upgrade
|
Book Value Per Share | 3.93 | 4.06 | 4.47 | 4.12 | 3.51 | 2.69 | Upgrade
|
Tangible Book Value | 2,930 | 3,035 | 3,436 | 3,213 | 2,673 | 2,050 | Upgrade
|
Tangible Book Value Per Share | 3.78 | 3.92 | 4.30 | 3.94 | 3.34 | 2.58 | Upgrade
|
Buildings | 1,233 | 1,260 | 890.61 | 812.74 | 555.36 | 473.23 | Upgrade
|
Machinery | 740.56 | 678.23 | 514.6 | 304.98 | 212.71 | 167.51 | Upgrade
|
Construction In Progress | 167.44 | 122.43 | 473.99 | 301.15 | 262.68 | 91.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.